title: Verapamil selectively inhibits expression of interleukin-2 messenger RNA in mitogen activated mononuclear blood cells.
authors: Charles A. Dana Research Institute, Boston, MA.
authors: B
authors: B
authors: Zanker
authors: G
authors: G
authors: Walz
authors: K J
authors: KJ
authors: Wieder
authors: M
authors: M
authors: Moscovitch-Lopatin
authors: B R
authors: BR
authors: Smith
authors: T B
authors: TB
authors: Strom
mesh_terms: D002118:Calcium / Q000097:blood; D002478:Cells, Cultured; D003600:Cytosol / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects*; D005796:Genes / Q000187:drug effects; D006801:Humans; D007376:Interleukin-2 / Q000235:genetics*; D008213:Lymphocyte Activation; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D014158:Transcription, Genetic / Q000187:drug effects*; D014700:Verapamil / Q000494:pharmacology*
chemical_list: D007376:Interleukin-2; D012333:RNA, Messenger; D014700:Verapamil; D002118:Calcium